A Dublin-based medical device start-up has completed a major regulatory milestone in its bid to transform treatment for chronic migraine sufferers across Europe, advancing a minimally invasive implantable system that could reduce the cost of neurostimulation surgery. Capri Medical, a smart medtech company founded in Dublin, is a lead partner in the EU-funded TARA consortium, which has announced completion of product development. The platform has…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.